Abstract:Objective To investigate the mechanism of apoptosis in colorectal cancer cells induced by oridonin through the ROS/JNK signaling pathway. Methods The MTT assay was used to detect the effect of oridonin on human colorectal cancer Caco2 and SW480 cells. Morphologic changes in cells were observed using Hoechst 33342 staining. Apoptotic cells were evaluated by flow cytometry, ROS were analyzed using DCFH-DA staining. Network pharmacology and molecular docking were conducted to predict potential ROS-related targets of oridonin (ORI) in colorectal cancer (CRC), which were verified by Western blot analysis. Results After Caco2 and SW480 cells were treated with oridonin, respectively, cell viability significantly decreased (P < 0.01 or 0.05). Chromatin condensation and loss of nuclear struction were observed using Hoechst 33342, which exhibited apoptotic characteristics. With the increase of oridonin concentration, the levels of the apoptotic cells, as well as the protein levels of Cleaved Caspase-3, Cleaved PARP, Bax, and p-JNK in CRC cells, were elevated, while Bcl-2 levels were downregulated (P < 0.01 or 0.05). ORI could dose-dependently increase ROS level in CRC cells (P < 0.01). However, N-Acetyl cysteine (NAC), the ROS scavenger, significantly reduced ROS levels induced by oridonin, downregulated p-JNK protein expression, abolished cell apoptosis, and increased cell viability (P < 0.01). The results of network pharmacology, molecular docking and Western blot indicated that the JNK pathway might be a target of ORI-induced apoptosis in CRC cells through ROS. Conclusion ORI can induce apoptosis in CRC cells via the ROS/JNK signaling pathway.